clinical trial · NCT00598208
A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)
Organon and Co·phase2·completed·n = 325
Fertilizationcorifollitropin alfaFollitropin beta injection
brief summary
The primary objective of this trial is to investigate the dose -response relationship of a single injection of Org 38286 to initiate multifollicular growth for the first seven days in a controlled ovarian hyperstimulation (COH) protocol for IVF or ICSI.
started
May 19, 2003
primary completion
Mar 15, 2004
completion
Mar 15, 2004
last updated
Aug 15, 2024
official title
A Phase 2, Open Label, Randomized Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or ICSI.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol